173 related articles for article (PubMed ID: 33421977)
1. Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.
Hoang T; Nguyen TQ; Tran TTA
Cancer Res Treat; 2021 Jul; 53(3):650-656. PubMed ID: 33421977
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
3. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S
Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902
[TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
[TBL] [Abstract][Full Text] [Related]
5. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
Tang Q; Wang Y; Ou L; Li J; Zheng K; Zhan H; Gu J; Zhou G; Xie S; Zhang J; Huang W; Wang S; Wang X
Int J Biol Sci; 2021; 17(8):1925-1939. PubMed ID: 34131396
[No Abstract] [Full Text] [Related]
7. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
8.
Bao R; Hernandez K; Huang L; Luke JJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675312
[TBL] [Abstract][Full Text] [Related]
9. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.
Ilikci Sagkan R; Akin-Bali DF
J Med Virol; 2020 Nov; 92(11):2637-2647. PubMed ID: 32492203
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous expression of ACE2, TMPRSS2, and FURIN at single-cell resolution in advanced non-small cell lung cancer.
Liu Z; Gu X; Li Z; Shan S; Wu F; Ren T
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3563-3573. PubMed ID: 35960376
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer that Highly Express Both
Wang H; Yang J
Pathol Oncol Res; 2021; 27():612969. PubMed ID: 34257580
[TBL] [Abstract][Full Text] [Related]
12. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress.
Rossi ÁD; de Araújo JLF; de Almeida TB; Ribeiro-Alves M; de Almeida Velozo C; Almeida JM; de Carvalho Leitão I; Ferreira SN; da Silva Oliveira J; Alves HJ; Scheid HT; Faffe DS; Galliez RM; de Ávila RE; Resende GG; Teixeira MM; ; da Costa Ferreira Júnior O; Castiñeiras TMPP; Souza RP; Tanuri A; Aguiar RS; Barroso SPC; Cardoso CC
Sci Rep; 2021 May; 11(1):9658. PubMed ID: 33958627
[TBL] [Abstract][Full Text] [Related]
13. Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.
Afshari A; Janfeshan S; Yaghobi R; Roozbeh J; Azarpira N
Infect Genet Evol; 2021 Mar; 88():104669. PubMed ID: 33301988
[TBL] [Abstract][Full Text] [Related]
14. Impact of
Fu J; Liu S; Tan Q; Liu Z; Qian J; Li T; Du J; Song B; Li D; Zhang L; He J; Guo K; Zhou B; Chen H; Fu S; Liu X; Cheng J; He T; Fu J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364238
[TBL] [Abstract][Full Text] [Related]
15. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
Fließer E; Birnhuber A; Marsh LM; Gschwandtner E; Klepetko W; Olschewski H; Kwapiszewska G
J Pathol Clin Res; 2021 Sep; 7(5):446-458. PubMed ID: 33978304
[TBL] [Abstract][Full Text] [Related]
16. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.
Singh H; Choudhari R; Nema V; Khan AA
Microb Pathog; 2021 Jan; 150():104621. PubMed ID: 33278516
[TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Angiotensin I-converting enzyme 2, type II transmembrane serine protease 2 and 4 in tree shrew indicate it as a potential animal model for SARS-CoV-2 infection.
Li N; Gu W; Lu C; Sun X; Tong P; Han Y; Wang W; Dai J
Bioengineered; 2021 Dec; 12(1):2836-2850. PubMed ID: 34227905
[TBL] [Abstract][Full Text] [Related]
19. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
Hou Y; Zhao J; Martin W; Kallianpur A; Chung MK; Jehi L; Sharifi N; Erzurum S; Eng C; Cheng F
BMC Med; 2020 Jul; 18(1):216. PubMed ID: 32664879
[TBL] [Abstract][Full Text] [Related]
20. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19.
Ahmadi M; Pashangzadeh S; Mousavi P; Saffarzadeh N; Amin Habibi M; Hajiesmaeili F; Rezaei N
Int Immunopharmacol; 2021 Jun; 95():107568. PubMed ID: 33765612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]